Product brochure enVast to be used as leave behind piece as needed.
Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round.
Flow model set up and breakdown pdf for viewing.
Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke.
As a board observer and senior advisor to the company, Earl Slee brings extensive medical device innovation and business development expertise.
As an independent board chairman, Mike Kujak will bring expert knowledge and know-how from his years of leadership in the medical device start-up space.
Vesalio Initiates Clinical Study Evaluating Innovative Thrombectomy Technique for Patients with STEMI
Vesalio announced the start of enrollment in its NATURE study using enVast™, the company’s first thrombectomy system for patients presenting with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.
Brand guidelines to show the Vesalio brand is to be used and presented to the public.
Report template for case feedback. Can also be used for complaints reporting.
Recommendations on microcatheters and frequently asked questions on microcatheter use with NeVa